ARNT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.936000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.298410E-01
Normal-vs-Stage2
3.312600E-01
Normal-vs-Stage3
3.847600E-02
Normal-vs-Stage4
5.960600E-01
Stage1-vs-Stage2
6.031800E-01
Stage1-vs-Stage3
4.228200E-01
Stage1-vs-Stage4
5.762100E-02
Stage2-vs-Stage3
2.419400E-01
Stage2-vs-Stage4
9.843700E-02
Stage3-vs-Stage4
2.748000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.672200E-01
Normal-vs-AfricanAmerican
9.536800E-01
Normal-vs-Asian
1.290350E-01
Caucasian-vs-AfricanAmerican
1.553590E-01
Caucasian-vs-Asian
5.384000E-01
AfricanAmerican-vs-Asian
1.415010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.606200E-01
Normal-vs-Female
2.189400E-01
Male-vs-Female
6.604400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.850000E-01
Normal-vs-Age(41-60Yrs)
4.550400E-01
Normal-vs-Age(61-80Yrs)
2.768600E-01
Normal-vs-Age(81-100Yrs)
2.275700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.065600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.940400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.490800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.939600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.322000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.658800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.359790E-01
Normal-vs-Daily Drinker
3.324000E-02
Normal-vs-Weekly Drinker
4.655200E-01
Normal-vs-Occasional Drinker
3.675000E-01
Normal-vs-Social Drinker
6.397800E-01
Non Drinker-vs-Daily Drinker
1.525840E-01
Non Drinker-vs-Weekly Drinker
2.065000E-01
Non Drinker-vs-Occasional Drinker
2.714400E-01
Non Drinker-vs-Social Drinker
1.837970E-01
Daily Drinker-vs-Weekly Drinker
2.137700E-02
Daily Drinker-vs-Occasional Drinker
2.445700E-02
Daily Drinker-vs-Social Drinker
2.769800E-02
Weekly Drinker-vs-Occasional Drinker
8.135200E-01
Weekly Drinker-vs-Social Drinker
8.791600E-01
Occasional Drinker-vs-Social Drinker
7.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.445030E-01
Normal-vs-Grade 2
8.702300E-03
Normal-vs-Grade 3
2.349900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.237900E-03
Grade 1-vs-Grade 3
3.528100E-02
Grade 1-vs-Grade 4
1.445030E-01
Grade 2-vs-Grade 3
8.811000E-01
Grade 2-vs-Grade 4
8.702300E-03
Grade 3-vs-Grade 4
2.349900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.957600E-01
Normal-vs-NonDiabetic
1.874000E-01
Diabetic-vs-NonDiabetic
9.433800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.306100E-02
Normal-vs-NoPancreatitis
2.609000E-01
Pancreatitis-vs-NoPancreatitis
5.634000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.403800E-01
Normal-vs-N1
3.026800E-01
N0-vs-N1
9.318000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.501000E-01
Normal-vs-TP53-NonMutant
5.353000E-01
TP53-Mutant-vs-TP53-NonMutant
3.529200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
